Skip to content

Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, sold GYRE on Jun 18, 2026

Data as of Oct 16

▼ SELL$19.1K3,000 shares at $6.35Weiguo Ye Chief Operating OfficerGYRE Gyre Therapeutics, Inc.
Watch GYRE
Traded
Jun 18, 2026
Disclosed
Jun 22, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, sold GYRE on Jun 18, 2026TRADEDDISCLOSED
GYRESimilar stocks (XLV — its sector index fund), rebased to GYRE's price on the disclosure day
GYRE since disclosure
−0.8%
after the sale
Similar stocks (XLV) since disclosure
+17.8%
XLV — its sector index fund

Change in closing price from Jun 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLWeiguo Ye Chief Operating OfficerGYRE Gyre Therapeutics, Inc.$31.2Kdisclosed Jun 22 · filed 12 days after the trade · late
  2. ▼ SELLWeiguo Ye Chief Operating OfficerGYRE Gyre Therapeutics, Inc.$18.4Kdisclosed Jun 22 · filed 13 days after the trade · late

See every trade on GYRE →